메뉴 건너뛰기




Volumn 105, Issue 1, 2011, Pages 88-95

Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets

Author keywords

Exosite; Platelet activation; Protease activated receptors; Thrombin

Indexed keywords

APTAMER; GAMMA THROMBIN; HD1; HD22; HIRUGEN; PADGEM PROTEIN; PHENYLALANYLPROLYLARGINYLCHLOROMETHYLKETONE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; RECEPTOR BLOCKING AGENT; SCH 79797; UNCLASSIFIED DRUG; YD 3;

EID: 78651089728     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-05-0305     Document Type: Article
Times cited : (14)

References (48)
  • 2
    • 38949215535 scopus 로고    scopus 로고
    • Thrombin and protease-activated receptors (PARs) in atherothrombosis
    • Martorell L, Martínez-González J, Rodríguez C, et al. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 2008; 99: 305-315.
    • (2008) Thromb Haemost , vol.99 , pp. 305-315
    • Martorell, L.1    Martínez-González, J.2    Rodríguez, C.3
  • 3
    • 28344436780 scopus 로고    scopus 로고
    • Protease-activated receptors in hemostasis, thrombosis and vascular biology
    • Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005; 3: 1800-1814.
    • (2005) J Thromb Haemost , vol.3 , pp. 1800-1814
    • Coughlin, S.R.1
  • 4
    • 33748495552 scopus 로고    scopus 로고
    • Protease-activated receptors in cardiovascular diseases
    • Leger AJ, Covic L, Kuliopulos A. Protease-activated receptors in cardiovascular diseases. Circulation 2006, 114: 1070-1077.
    • (2006) Circulation , vol.114 , pp. 1070-1077
    • Leger, A.J.1    Covic, L.2    Kuliopulos, A.3
  • 5
    • 47149108319 scopus 로고    scopus 로고
    • Pharmacological strategies for inhibition of thrombin activity
    • Alban S. Pharmacological strategies for inhibition of thrombin activity. Curr Pharm Des 2008; 14: 1152-1175.
    • (2008) Curr Pharm Des , vol.14 , pp. 1152-1175
    • Alban, S.1
  • 6
    • 68349093744 scopus 로고    scopus 로고
    • Novel anticoagulants in clinical development: Focus on factor Xa and direct thrombin inhibitors
    • Steffel J, Lüscher TF. Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors. J Cardiovasc Med 2009; 10: 616-623.
    • (2009) J Cardiovasc Med , vol.10 , pp. 616-623
    • Steffel, J.1    Lüscher, T.F.2
  • 7
    • 0141484541 scopus 로고    scopus 로고
    • Thrombin interactions
    • Di Cera E. Thrombin interactions. Chest 2003; 124: 11S-17S.
    • (2003) Chest , vol.124
    • Di Cera, E.1
  • 8
    • 17644371341 scopus 로고    scopus 로고
    • Exosite-driven substrate specificity and function in coagulation
    • Krishnaswamy S. Exosite-driven substrate specificity and function in coagulation. J Thromb Haemost 2005; 3: 54-67.
    • (2005) J Thromb Haemost , vol.3 , pp. 54-67
    • Krishnaswamy, S.1
  • 9
    • 34250778996 scopus 로고    scopus 로고
    • Exosites in the substrate specificity of blood coagulation reactions
    • Bock PE, Panizzi P, Verhamme IM. Exosites in the substrate specificity of blood coagulation reactions. J Thromb Haemost 2007; 5: S81-S94.
    • (2007) J Thromb Haemost , vol.5
    • Bock, P.E.1    Panizzi, P.2    Verhamme, I.M.3
  • 10
    • 0037166273 scopus 로고    scopus 로고
    • Three-dimensional modeling of thrombin-fibrinogen interaction
    • Rose T, Di Cera E. Three-dimensional modeling of thrombin-fibrinogen interaction. J Biol Chem 2002; 277: 18875-18880.
    • (2002) J Biol Chem , vol.277 , pp. 18875-18880
    • Rose, T.1    Di Cera, E.2
  • 11
    • 34548456509 scopus 로고    scopus 로고
    • Beyond unfractionated heparin and warfarin: Current and future advances
    • Hirsh J, O'Donnell M, Eikelboom JW. Beyond unfractionated heparin and warfarin: current and future advances. Circulation 2007; 116: 552-560.
    • (2007) Circulation , vol.116 , pp. 552-560
    • Hirsh, J.1    O'Donnell, M.2    Eikelboom, J.W.3
  • 12
    • 60549114198 scopus 로고    scopus 로고
    • Development of new anticoagulants: Present and future
    • Harenberg J. Development of new anticoagulants: present and future. Semin Thromb Hemost 2008; 34: 779-793.
    • (2008) Semin Thromb Hemost , vol.34 , pp. 779-793
    • Harenberg, J.1
  • 14
    • 0030858230 scopus 로고    scopus 로고
    • Low-molecular-weight heparins
    • Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337: 688-698.
    • (1997) N Engl J Med , vol.337 , pp. 688-698
    • Weitz, J.I.1
  • 15
    • 33845480738 scopus 로고    scopus 로고
    • Direct thrombin inhibitors - A survey of recent developments
    • Schwienhorst A. Direct thrombin inhibitors - a survey of recent developments. Cell Mol Life Sci 2006; 63: 2773-2791.
    • (2006) Cell Mol Life Sci , vol.63 , pp. 2773-2791
    • Schwienhorst, A.1
  • 16
    • 0024996181 scopus 로고
    • The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alphathrombin on fibrinogen
    • Naski MC, Fenton JW 2nd, Maraganore JM, et al. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alphathrombin on fibrinogen. J Biol Chem 1990; 265: 13484-13489.
    • (1990) J Biol Chem , vol.265 , pp. 13484-13489
    • Naski, M.C.1    Fenton II, J.W.2    Maraganore, J.M.3
  • 17
    • 0028236301 scopus 로고
    • Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system
    • Claeson G. Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system. Blood Coagul Fibrinolysis 1994; 5: 411-436.
    • (1994) Blood Coagul Fibrinolysis , vol.5 , pp. 411-436
    • Claeson, G.1
  • 19
    • 0027773082 scopus 로고
    • Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding
    • Schumacher WA, Steinbacher TE, Heran CL, et al. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding. J Pharmacol Exp Ther 1993; 267: 1237-1242.
    • (1993) J Pharmacol Exp Ther , vol.267 , pp. 1237-1242
    • Schumacher, W.A.1    Steinbacher, T.E.2    Heran, C.L.3
  • 20
    • 0030610285 scopus 로고    scopus 로고
    • Antithrombotic effects of NE-6505, a novel anion-binding exosite inhibitor
    • Muramatsu R, Sasaki M, Watanabe N, et al. Antithrombotic effects of NE-6505, a novel anion-binding exosite inhibitor. Thromb Res 1997; 86: 453-460.
    • (1997) Thromb Res , vol.86 , pp. 453-460
    • Muramatsu, R.1    Sasaki, M.2    Watanabe, N.3
  • 21
    • 0026780909 scopus 로고
    • Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin
    • Kelly AB, Maraganore JM, Bourdon P, et al. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin. Proc Natl Acad Sci USA 1992; 89: 6040-6044.
    • (1992) Proc Natl Acad Sci USA , vol.89 , pp. 6040-6044
    • Kelly, A.B.1    Maraganore, J.M.2    Bourdon, P.3
  • 22
    • 0035501805 scopus 로고    scopus 로고
    • Molecular mapping of thrombin-receptor interactions
    • Ayala YM, Cantwell AM, Rose T, et al. Molecular mapping of thrombin-receptor interactions. Proteins 2001; 45:107-116.
    • (2001) Proteins , vol.45 , pp. 107-116
    • Ayala, Y.M.1    Cantwell, A.M.2    Rose, T.3
  • 23
    • 0034611727 scopus 로고    scopus 로고
    • PAR3 is a cofactor for PAR4 activation by thrombin
    • Nakanishi-Matsui M, Zheng YW, Sulciner DJ, et al. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404: 609-613.
    • (2000) Nature , vol.404 , pp. 609-613
    • Nakanishi-Matsui, M.1    Zheng, Y.W.2    Sulciner, D.J.3
  • 24
    • 0344925961 scopus 로고    scopus 로고
    • Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage
    • Jacques SL, Kuliopulos A. Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage. Biochem J 2003; 376: 733-740.
    • (2003) Biochem J , vol.376 , pp. 733-740
    • Jacques, S.L.1    Kuliopulos, A.2
  • 25
    • 0025174706 scopus 로고
    • Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin
    • Jakubowski JA, Maraganore JM. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Blood 1990; 75: 399-406.
    • (1990) Blood , vol.75 , pp. 399-406
    • Jakubowski, J.A.1    Maraganore, J.M.2
  • 26
    • 0026575221 scopus 로고
    • Selection of single-stranded DNA molecules that bind and inhibit human thrombin
    • Bock LC, Griffin LC, Latham JA, et al. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992; 355: 564-566.
    • (1992) Nature , vol.355 , pp. 564-566
    • Bock, L.C.1    Griffin, L.C.2    Latham, J.A.3
  • 27
    • 28544449246 scopus 로고    scopus 로고
    • 2-(2-Br-phenyl)-8-methoxy- Benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets
    • Wu CC, Wang TW, Wang WY, et al. 2-(2-Br-phenyl)-8-methoxy- benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Eur J Pharmacol 2005; 527: 37-43.
    • (2005) Eur J Pharmacol , vol.527 , pp. 37-43
    • Wu, C.C.1    Wang, T.W.2    Wang, W.Y.3
  • 28
    • 33748933392 scopus 로고    scopus 로고
    • Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor
    • Wang WY, Wu YC, Wu CC. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor. Mol Pharmacol 2006; 70: 1380-1389.
    • (2006) Mol Pharmacol , vol.70 , pp. 1380-1389
    • Wang, W.Y.1    Wu, Y.C.2    Wu, C.C.3
  • 29
    • 33748307543 scopus 로고    scopus 로고
    • Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation
    • Wu CC, Teng CM. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. Eur J Pharmacol 2006; 546: 142-147.
    • (2006) Eur J Pharmacol , vol.546 , pp. 142-147
    • Wu, C.C.1    Teng, C.M.2
  • 30
    • 0037213645 scopus 로고    scopus 로고
    • Evaluation of DNA aptamers directed to thrombin as potential thrombus imaging agents
    • Dougan H, Weitz JI, Stafford AR, et al. Evaluation of DNA aptamers directed to thrombin as potential thrombus imaging agents. Nucl Med Biol 2003; 30: 61-72.
    • (2003) Nucl Med Biol , vol.30 , pp. 61-72
    • Dougan, H.1    Weitz, J.I.2    Stafford, A.R.3
  • 31
    • 0034670162 scopus 로고    scopus 로고
    • Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1- methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist
    • Ahn HS, Foster C, Boykow G, et al. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol 2000; 60: 1425-1434.
    • (2000) Biochem Pharmacol , vol.60 , pp. 1425-1434
    • Ahn, H.S.1    Foster, C.2    Boykow, G.3
  • 32
    • 0036175589 scopus 로고    scopus 로고
    • Role of inflammatory mediators in thrombogenesis
    • Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther 2002; 300: 729-735.
    • (2002) J Pharmacol Exp Ther , vol.300 , pp. 729-735
    • Shebuski, R.J.1    Kilgore, K.S.2
  • 33
    • 3442884607 scopus 로고    scopus 로고
    • P-selectin in haemostasis
    • Andre P. P-selectin in haemostasis. Br J Haematol 2004; 126: 298-306.
    • (2004) Br J Haematol , vol.126 , pp. 298-306
    • Andre, P.1
  • 34
    • 0037769793 scopus 로고    scopus 로고
    • Platelet P-selectin facilitates atherosclerotic lesion development
    • Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101: 2661-2666.
    • (2003) Blood , vol.101 , pp. 2661-2666
    • Burger, P.C.1    Wagner, D.D.2
  • 35
    • 0033559805 scopus 로고    scopus 로고
    • Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
    • Kahn ML, Nakanishi-Matsui M, Shapiro MJ, et al. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103: 879-887.
    • (1999) J Clin Invest , vol.103 , pp. 879-887
    • Kahn, M.L.1    Nakanishi-Matsui, M.2    Shapiro, M.J.3
  • 37
    • 55249083317 scopus 로고    scopus 로고
    • Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin
    • Ofosu FA, Dewar L, Craven SJ, et al. Coordinate activation of human platelet protease-activated receptor-1 and -4 in response to subnanomolar alpha-thrombin. J Biol Chem 2008; 283: 26886-26893.
    • (2008) J Biol Chem , vol.283 , pp. 26886-26893
    • Ofosu, F.A.1    Dewar, L.2    Craven, S.J.3
  • 38
    • 0036287538 scopus 로고    scopus 로고
    • Thrombin receptor antagonists; recent advances in PAR-1 antagonist development
    • Anderluh M, Dolenc MS. Thrombin receptor antagonists; recent advances in PAR-1 antagonist development. Curr Med Chem 2002; 9: 1229-1250.
    • (2002) Curr Med Chem , vol.9 , pp. 1229-1250
    • Anderluh, M.1    Dolenc, M.S.2
  • 39
    • 0036285450 scopus 로고    scopus 로고
    • Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3
    • Wu CC, Hwang TL, Liao CH, et al. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3. Thromb Haemost 2002; 87: 1026-1033.
    • (2002) Thromb Haemost , vol.87 , pp. 1026-1033
    • Wu, C.C.1    Hwang, T.L.2    Liao, C.H.3
  • 40
    • 0042563229 scopus 로고    scopus 로고
    • The role of PAR4 in thrombin-induced thromboxane production in human platelets
    • Wu CC, Hwang TL, Liao CH, et al. The role of PAR4 in thrombin-induced thromboxane production in human platelets. Thromb Haemost 2003; 90: 299-308.
    • (2003) Thromb Haemost , vol.90 , pp. 299-308
    • Wu, C.C.1    Hwang, T.L.2    Liao, C.H.3
  • 41
    • 0026598494 scopus 로고
    • Thrombin-specific inhibition by and slow cleavage of hirulog-1
    • Witting JI, Bourdon P, Brezniak DV, et al. Thrombin-specific inhibition by and slow cleavage of hirulog-1. Biochem J 1992; 283: 737-743.
    • (1992) Biochem J , vol.283 , pp. 737-743
    • Witting, J.I.1    Bourdon, P.2    Brezniak, D.V.3
  • 42
    • 0028797819 scopus 로고
    • Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system
    • Bouton MC, Jandrot-Perrus M, Moog S, et al. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system. Biochem J 1995; 305: 635-641.
    • (1995) Biochem J , vol.305 , pp. 635-641
    • Bouton, M.C.1    Jandrot-Perrus, M.2    Moog, S.3
  • 43
    • 0032499696 scopus 로고    scopus 로고
    • Cloning and characterization of human protease-activated receptor 4
    • Xu WF, Andersen H, Whitmore TE, et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998; 95: 6642-6646.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 6642-6646
    • Xu, W.F.1    Andersen, H.2    Whitmore, T.E.3
  • 44
    • 0035877749 scopus 로고    scopus 로고
    • Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib
    • Soslau G, Class R, Morgan DA, et al. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001; 276: 21173-21183.
    • (2001) J Biol Chem , vol.276 , pp. 21173-21183
    • Soslau, G.1    Class, R.2    Morgan, D.A.3
  • 45
    • 2442486445 scopus 로고    scopus 로고
    • Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin
    • Soslau G, Goldenberg SJ, Class R, et al. Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin. Platelets 2004; 15: 155-166.
    • (2004) Platelets , vol.15 , pp. 155-166
    • Soslau, G.1    Goldenberg, S.J.2    Class, R.3
  • 46
    • 0020505313 scopus 로고
    • Thrombin-platelet interactions: An assessment of the roles of saturable and nonsaturable binding in platelet activation
    • Alexander RJ, Fenton JW 2nd, Detwiler TC. Thrombin-platelet interactions: an assessment of the roles of saturable and nonsaturable binding in platelet activation. Arch Biochem Biophys 1983; 222: 266-275.
    • (1983) Arch Biochem Biophys , vol.222 , pp. 266-275
    • Alexander, R.J.1    Fenton II, J.W.2    Detwiler, T.C.3
  • 47
    • 20444436800 scopus 로고    scopus 로고
    • Nucleic acid aptamers in therapeutic anticoagulation. Technology, development and clinical application
    • Becker RC, Rusconi C, Sullenger B. Nucleic acid aptamers in therapeutic anticoagulation. Technology, development and clinical application. Thromb Haemost 2005; 93: 1014-1020.
    • (2005) Thromb Haemost , vol.93 , pp. 1014-1020
    • Becker, R.C.1    Rusconi, C.2    Sullenger, B.3
  • 48
    • 52049111643 scopus 로고    scopus 로고
    • Anti-coagulant aptamers
    • Gopinath SC. Anti-coagulant aptamers. Thromb Res 2008; 122: 838-847.
    • (2008) Thromb Res , vol.122 , pp. 838-847
    • Gopinath, S.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.